Business Description
Standard Chemical & Pharmaceutical Co Ltd
ISIN : TW0001720001
Total Employee Number:
1,130Compare
Compare
Traded in other countries / regions
1720.Taiwan Index Membership
TSEC Weighted Index IPO Date
1995-12-12Description
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.24 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | 0.49 | |||||
Interest Coverage | 151.03 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 3.86 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.3 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | 3.6 | |||||
3-Year FCF Growth Rate | 246.7 | |||||
3-Year Book Growth Rate | 8.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.05 | |||||
9-Day RSI | 38.5 | |||||
14-Day RSI | 40.96 | |||||
3-1 Month Momentum % | 2.75 | |||||
6-1 Month Momentum % | -4.9 | |||||
12-1 Month Momentum % | 13.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.18 | |||||
Quick Ratio | 1.54 | |||||
Cash Ratio | 0.88 | |||||
Days Inventory | 144.67 | |||||
Days Sales Outstanding | 59.07 | |||||
Days Payable | 35.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.58 | |||||
Dividend Payout Ratio | 0.5 | |||||
3-Year Dividend Growth Rate | 3.8 | |||||
Forward Dividend Yield % | 3.58 | |||||
5-Year Yield-on-Cost % | 6.65 | |||||
Shareholder Yield % | 1.46 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.6 | |||||
Operating Margin % | 20.51 | |||||
Net Margin % | 14.51 | |||||
EBITDA Margin % | 30.21 | |||||
FCF Margin % | 16.77 | |||||
OCF Margin % | 23.27 | |||||
ROE % | 17.12 | |||||
ROA % | 8.64 | |||||
ROIC % | 14.58 | |||||
3-Year ROIIC % | 21.85 | |||||
ROC (Joel Greenblatt) % | 28.27 | |||||
ROCE % | 18.01 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 11.01 | |||||
Forward PE Ratio | 10.83 | |||||
PE Ratio without NRI | 11.01 | |||||
Shiller PE Ratio | 14.74 | |||||
Price-to-Owner-Earnings | 13.82 | |||||
PEG Ratio | 0.74 | |||||
PS Ratio | 1.59 | |||||
PB Ratio | 1.77 | |||||
Price-to-Tangible-Book | 1.84 | |||||
Price-to-Free-Cash-Flow | 9.36 | |||||
Price-to-Operating-Cash-Flow | 6.78 | |||||
EV-to-EBIT | 7.56 | |||||
EV-to-EBITDA | 6.01 | |||||
EV-to-Revenue | 1.81 | |||||
EV-to-FCF | 10.81 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 0.81 | |||||
Price-to-DCF (Earnings Based) | 0.57 | |||||
Price-to-DCF (FCF Based) | 0.55 | |||||
Price-to-Median-PS-Value | 0.98 | |||||
Price-to-Peter-Lynch-Fair-Value | 1 | |||||
Price-to-Graham-Number | 0.95 | |||||
Earnings Yield (Greenblatt) % | 13.23 | |||||
FCF Yield % | 10.79 | |||||
Forward Rate of Return (Yacktman) % | 17.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Standard Chemical & Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 7,079.538 | ||
| EPS (TTM) (NT$) | 5.088 | ||
| Beta | -0.065 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 19.2 | ||
| 14-Day RSI | 40.96 | ||
| 14-Day ATR (NT$) | 0.791038 | ||
| 20-Day SMA (NT$) | 56.605 | ||
| 12-1 Month Momentum % | 13.8 | ||
| 52-Week Range (NT$) | 48.636363 - 60.7 | ||
| Shares Outstanding (Mil) | 196.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Standard Chemical & Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Standard Chemical & Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 2.000000 Cash Dividend | 2026-07-23 | 57.73 (-1.09%) | ||
| 1.1:1 Stock Split | 2026-07-23 | 57.73 (-1.09%) | ||
| TWD 2.545455 Cash Dividend | 2025-08-06 | 52.91 (+0.34%) | ||
| 1.07:1 Stock Split | 2011-08-19 | 24.21 (-1.38%) | ||
| 1.03:1 Stock Split | 2009-07-20 | 25.16 (+5.17%) | ||
| 1.03:1 Stock Split | 2006-08-18 | 13.93 (+0.58%) | ||
| 1.03:1 Stock Split | 2003-08-14 | 13.70 (+0.54%) | ||
| 1.05:1 Stock Split | 2002-08-07 | 12.90 (+4.30%) | ||
| 1.05:1 Stock Split | 2001-08-07 | 14.59 (+0.83%) | ||
| 1.1:1 Stock Split | 2000-07-20 | 15.50 (-3.42%) |
Show
Entries
Standard Chemical & Pharmaceutical Co Ltd Frequently Asked Questions
What is Standard Chemical & Pharmaceutical Co Ltd(TPE:1720)'s stock price today?
The current price of TPE:1720 is NT$56.00. The 52 week high of TPE:1720 is NT$60.70 and 52 week low is NT$48.64.
When is next earnings date of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720)?
The next earnings date of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) is .
Does Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) pay dividends? If so, how much?
The Dividend Yield %  of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) is 3.58% (As of Today), Highest Dividend Payout Ratio of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) was 0.75. The lowest was 0.26. And the median was 0.54. The  Forward Dividend Yield % of Standard Chemical & Pharmaceutical Co Ltd(TPE:1720) is 3.58%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Standard Chemical & Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers